Antitumor slow-release implant having strong adhesion and hemostasis functions and preparation method thereof
A slow-release implant and anti-tumor technology, which is applied in the direction of anti-tumor drugs, medical preparations with no active ingredients, medical preparations containing active ingredients, etc. It can solve the problems of easy metastasis of cancer cells, easy bleeding of wounds, and easy inflammation and other problems, to achieve the effect of stable self-healing performance, beneficial to clinical application, and good injection performance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0047] Example 1: Preparation of a non-drug-loaded anti-tumor sustained-release implant with strong adhesion and hemostatic functions
[0048] Chitosan (1.3104 g, 8 mmol) and 1-hydroxybenzotriazole monohydrate (1.1480 g, 8 mmol) were dissolved in 100 mL of deionized water, and stirred overnight until the solution was clear and transparent. 40mL of gallic acid solution (0.3872g, 2mmol) was added dropwise in the chitosan solution, and then 2mL of 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride was added dropwise. Ethanol solution (0.3437g, 2mmol). The mixed system was reacted for 24 hours at room temperature (25° C.) and protected from light. After the reaction, the reactant was poured into a dialysis bag (MWCO 14000Da), and dialyzed at 37° C. for 16 hours under nitrogen protection, and the water in the dialysis system was changed every 2 hours. After the dialysis is completed, the obtained product is freeze-dried to obtain a gallic acid-grafted chitosan copolymer, ...
Embodiment 2
[0055] Example 2: Preparation of an anti-tumor sustained-release implant loaded with doxorubicin with strong adhesion and hemostatic functions
[0056] The CSG precursor was prepared in the same manner as in Example 1.
[0057] Weigh 30 mg of lyophilized CSG precursor, dissolve it in 900 μL of 360 μg / mL doxorubicin hydrochloride solution, and after ultrasonic stirring for 10 min, add 100 μL of FeCl 3 ·6H 2 O (25mM) solution, after ultrasonication for 30 minutes, an anti-tumor sustained-release implant loaded with doxorubicin with strong adhesion and hemostatic functions was obtained.
[0058] MDL-III-808-2 laser and Fluke TI400IR thermal imager were used to evaluate the photothermal performance of the anti-tumor sustained-release implant (1mL) loaded with doxorubicin in this embodiment, which has strong adhesion and hemostatic functions, and at the same time Taking aqueous solution as a control, the Figure 10 It can be seen that the implant has good photothermal conversion...
PUM
Property | Measurement | Unit |
---|---|---|
length | aaaaa | aaaaa |
width | aaaaa | aaaaa |
thickness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com